ACORD announced today the winner of the ACORD Student Challenge 2025, a first-of-its-kind national competition that empowers university students to leverage cutting-edge technology to optimize ...
Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released the following note authored by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback